Literature DB >> 18262180

Dysregulation of Ack1 inhibits down-regulation of the EGF receptor.

Lene Melsaether Grøvdal1, Lene E Johannessen, Marianne Skeie Rødland, Inger Helene Madshus, Espen Stang.   

Abstract

The protein tyrosine kinase Ack1 has been linked to cancer when over-expressed. Ack1 has also been suggested to function in clathrin-mediated endocytosis and in down-regulation of the epidermal growth factor (EGF) receptor (EGFR). We have studied the intracellular localization of over-expressed Ack1 and found that Ack1 co-localizes with the EGFR upon EGF-induced endocytosis in cells with moderate over-expression of Ack. This co-localization is mainly observed in early endosomes. Furthermore, we found that over-expression of Ack1 retained the EGFR at the limiting membrane of early endosomes, inhibiting sorting to inner vesicles of multivesicular bodies. Down-regulation of Ack1 in HeLa cells resulted in reduced rate of (125)I-EGF internalization, whereas internalization of (125)I-transferrin was not affected. In cells where Ack1 had been knocked down by siRNA, recycling of internalized (125)I-EGF was increased, while degradation of (125)I-EGF was inhibited. Together, these data suggest that Ack1 is involved in an early step of EGFR desensitization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18262180     DOI: 10.1016/j.yexcr.2007.12.017

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  20 in total

1.  Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cells.

Authors:  Boon Tin Chua; Shu Jing Lim; Su Chin Tham; Wei Jie Poh; Axel Ullrich
Journal:  Mol Oncol       Date:  2010-03-19       Impact factor: 6.603

2.  Conserved tyrosine kinase promotes the import of silencing RNA into Caenorhabditis elegans cells.

Authors:  Antony M Jose; Yunsoo A Kim; Steven Leal-Ekman; Craig P Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-21       Impact factor: 11.205

3.  RhoB links PDGF signaling to cell migration by coordinating activation and localization of Cdc42 and Rac.

Authors:  Minzhou Huang; Lauren Satchell; James B Duhadaway; George C Prendergast; Lisa D Laury-Kleintop
Journal:  J Cell Biochem       Date:  2011-06       Impact factor: 4.429

4.  Cancer-associated mutations activate the nonreceptor tyrosine kinase Ack1.

Authors:  Victoria Prieto-Echagüe; Azad Gucwa; Barbara P Craddock; Deborah A Brown; W Todd Miller
Journal:  J Biol Chem       Date:  2010-01-28       Impact factor: 5.157

5.  Down-regulation of active ACK1 is mediated by association with the E3 ubiquitin ligase Nedd4-2.

Authors:  Wing Chan; Rui Tian; Yeow-Fong Lee; Soon Tuck Sit; Louis Lim; Ed Manser
Journal:  J Biol Chem       Date:  2009-01-14       Impact factor: 5.157

6.  Regulation of Ack1 localization and activity by the amino-terminal SAM domain.

Authors:  Victoria Prieto-Echagüe; Azad Gucwa; Deborah A Brown; W Todd Miller
Journal:  BMC Biochem       Date:  2010-10-27       Impact factor: 4.059

Review 7.  ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferation.

Authors:  Kiran Mahajan; Nupam P Mahajan
Journal:  Cancer Lett       Date:  2013-04-15       Impact factor: 8.679

8.  Cytoplasmic ACK1 interaction with multiple receptor tyrosine kinases is mediated by Grb2: an analysis of ACK1 effects on Axl signaling.

Authors:  Lin Pao-Chun; Perry M Chan; Wing Chan; Ed Manser
Journal:  J Biol Chem       Date:  2009-10-08       Impact factor: 5.157

9.  Synthetic lethality of TNK2 inhibition in PTPN11-mutant leukemia.

Authors:  Chelsea Jenkins; Samuel B Luty; Julia E Maxson; Christopher A Eide; Melissa L Abel; Corinne Togiai; Eneida R Nemecek; Daniel Bottomly; Shannon K McWeeney; Beth Wilmot; Marc Loriaux; Bill H Chang; Jeffrey W Tyner
Journal:  Sci Signal       Date:  2018-07-17       Impact factor: 8.192

10.  Identification and Characterization of Tyrosine Kinase Nonreceptor 2 Mutations in Leukemia through Integration of Kinase Inhibitor Screening and Genomic Analysis.

Authors:  Julia E Maxson; Melissa L Abel; Jinhua Wang; Xianming Deng; Sina Reckel; Samuel B Luty; Huahang Sun; Julie Gorenstein; Seamus B Hughes; Daniel Bottomly; Beth Wilmot; Shannon K McWeeney; Jerald Radich; Oliver Hantschel; Richard E Middleton; Nathanael S Gray; Brian J Druker; Jeffrey W Tyner
Journal:  Cancer Res       Date:  2015-12-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.